Physician profile

David L Navratil

Clinical Cardiac Electrophysiology · Las Vegas, NV

NPI 1043267024

$29,372.76

in general payments reported to CMS, 2019-2025

41 companies · $5,715 in 2025

The $5,715 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,908.69
Travel and Lodging$5,002.46

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $9,649.29 2019-2025 Farapulse, General - Therapies, Watchman Flx
Atricure, INC. $3,812.01 2019-2024
Abbott Laboratories $2,325.04 2019-2024 Cardiomems, Jot Dx, Aveir
Medtronic Vascular, INC. $2,109.10 2019-2020
Medtronic, INC. $1,988.56 2021-2025 Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan
Elutia, INC. $1,713.37 2019-2024 Ecm Patch,Pouch
Novartis Pharmaceuticals Corporation $832.51 2019-2024
Philips North America LLC $787.99 2022-2024 (9520) Igt Devices Undivided
Janssen Pharmaceuticals, INC $772.65 2019-2024 Xarelto
E.R. Squibb & Sons, L.L.C. $642.18 2019-2025 Camzyos
Zoll Respicardia, INC. $611.74 2021-2023 Remede System
Cvrx, INC. $609.55 2022-2025 Barostim Neo System
Merck Sharp & Dohme LLC $555.87 2021-2025 Verquvo, Capvaxive
Cook Medical LLC $357.38 2020-2024 Evolution
Kestra Medical Technology Services, INC. $278.51 2023 Assure Wcd
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $248.70 2020-2025 Repatha, Repatha
Boehringer Ingelheim Pharmaceuticals, INC. $229.20 2020-2025 Jardiance
Bayer Healthcare Pharmaceuticals INC. $201.28 2021-2025
Novo Nordisk INC $196.49 2021-2025 Wegovy, Ozempic, Rybelsus
Astellas Pharma US INC $196.47 2021
Sanofi-Aventis U.S. LLC $150.01 2019-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $146.30 2021-2023 Lifevest
W. L. Gore & Associates, INC. $124.09 2021-2022
Vital Connect, INC $100.84 2023 Vitalpatch Rtm
Alnylam Pharmaceuticals INC. $93.06 2021-2025 Amvuttra
Biosense Webster, INC. $91.96 2020
Abiomed $91.33 2020-2024 Impella
Actelion Pharmaceuticals US, INC. $71.55 2022-2025 Uptravi, Opsumit
Bridgebio Pharma, INC. $62.81 2025 Attruby
Pfizer INC. $50.12 2023-2025
Regeneron Healthcare Solutions, INC. $37.81 2025 Evkeeza
Kiniksa Pharmaceuticals, LTD. $36.09 2021-2023 Arcalyst
Lexicon Pharmaceuticals, INC. $35.06 2023 Inpefa
Preventice Services, LLC $34.13 2019
Kiniksa Pharmaceuticals International, Plc $28.14 2024 Arcalyst
Davol INC. $27.04 2020
Janssen Biotech, INC. $17.74 2024 Stelara
Medicomp INC $16.80 2019
Astrazeneca Pharmaceuticals LP $15.99 2021
Amarin Pharma, INC. $12.50 2021
Convatec INC. $11.50 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David L Navratil

$29,372.76

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $5,715 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/46681/david-l-navratil

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.